Stay updated on Efficacy Safety OTL-101 Cryopreserved ADA-SCID Clinical Trial
Sign up to get notified when there's something new on the Efficacy Safety OTL-101 Cryopreserved ADA-SCID Clinical Trial page.
Latest updates to the Efficacy Safety OTL-101 Cryopreserved ADA-SCID Clinical Trial page
- Check7 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.1%
- Check14 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study and includes a reference to the Contacts and Locations section.SummaryDifference3%
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedSeveral key resources related to genetics and rare diseases have been removed, including links to MedlinePlus and NIH databases, which may impact access to important health information.SummaryDifference5%
- Check43 days agoChange DetectedThe website has been updated to version 2.12.2, with numerous new links added to resources on genetics, rare diseases, and clinical trials, enhancing access to information on conditions like adenosine deaminase deficiency and severe combined immunodeficiency.SummaryDifference5%
- Check50 days agoChange DetectedThe website has been updated from version v2.12.0 to v2.12.1.SummaryDifference0.1%
- Check58 days agoChange DetectedThe website has been updated from version 2.11.2 to 2.12.0, indicating a new release with potential enhancements or features.SummaryDifference0.2%
Stay in the know with updates to Efficacy Safety OTL-101 Cryopreserved ADA-SCID Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy Safety OTL-101 Cryopreserved ADA-SCID Clinical Trial page.